Notice: Get a jump on 2015 — Pay your 2015 ASA membership dues now!




January 23 - 25 2015, 12:00 AM - 12:00 AM


February 07 - 08 2015, 12:00 AM - 12:00 AM

ASA Certificate in Business Administration 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit



December 18, 2014

0.9 Percent Sodium Chloride Injection USP in 100 mL MINI-BAG PLUS Container by Baxter: Recall - Particulate Matter


FDA MedWatch Recall - Particulate Matter

November 21, 2014

FDA MedWatch - Respironics California, Esprit V1000 and V200 Ventilators: Class I Recall - Power Failure May Occur


FDA MedWatch Respironics California Esprit V1000 and V200 Ventilators Class I Recall

November 21, 2014

FDA MedWatch - Highly Concentrated Potassium Chloride Injection, 10 mEq per 100 mL by Baxter: Recall - Mislabeled


Highly Concentrated Potassium Chloride Injection 10 mEq per 100 mL by Baxter Recall Mislabeled



Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

The Joint Commission Adopts ASA Recommendations on Medication Management Issues

Tuesday, May 17, 2011

The Joint Commission has adopted many recommendations on medication management issues suggested in a December 2010 letter from the American Society of Anesthesiologists (ASA), American Association of Nurse Anesthetists (AANA), American Academy of Anesthesiologist Assistants (AAAA) and the Anesthesia Patient Safety Foundation (APSF).

ASA specifically appreciates the following clarifications and modifications made by The Joint Commission:

• Deleting of the NPSG 03.04.01 FAQ prohibiting pre-labeling of syringes. We can agree with a general requirement of syringe labeling while allowing hospitals and providers to determine when and how they meet this standard.

• Clarifying that anesthesia providers may carry appropriate medications on their body as long as the institution has and enforces written policies.

• Clarifying that authorized personnel may be present around unlocked medication carts as long as such carts are located in a secured area and the hospital has and enforces written policies. 

• Clarifying that MM.06.01.01 EP9 with respect to informed consent was intended for medications ordered to treat conditions rather than anesthesia services.  Thus, anesthesiologists are not required to explain all of the possible effects of the dozens of medications that might be used during a surgical procedure as part of the informed consent process.

Click here to read the original December 2010 joint letter signed by ASA.

Click here to read the letter from The Joint Commission adopting some of the recommendations.


« Back to Washington Alerts